SHG Provides Compensation Analysis to GB Sciences, Inc.
SHG is pleased to announce it has completed a detailed compensation analysis for GB Sciences, Inc., for the benefit of attracting and retaining the senior leadership team. Our analysis was used among management and its advisors.
About GB Sciences, Inc.
GB Sciences is a biopharmaceutical and cannabinoid-based drug development company whose goal is to create patented formulations for safe, standardized, cannabinoid therapies that target a variety of medical conditions in both the pharmaceutical and wellness markets. To learn more about GB Sciences please visit Home - GB Sciences.
Prepare your business for buyers and due diligence with expert tips on financials, VDR setup, transaction teams, and valuation. Start your exit strong.
Learn how to increase your company's value before selling. Discover key strategies to improve reporting, reduce owner dependence, and attract buyers.
